Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Sharif N Natheir"'
Autor:
Elizabeth R. Gerstner, Bruce R. Rosen, Eva-Maria Ratai, Jorg Dietrich, Pratik Talati, Otto Rapalino, Deborah Forst, Ovidiu C. Andronesi, Sharif N Natheir, Jayashree Kalpathy-Cramer, Mark Vangel, Yi-Fen Yen, Daniel Kim, Ramon Gonzalez, Tracy T. Batchelor, Melanie Fu, Michael Wenke, Mohamed El-Abtah, Isabel Arrillaga-Romany, Julian He, Anna Vaynrub
Publikováno v:
Neuro Oncol
Patients with recurrent glioblastoma (rGBM) are often started on anti-angiogenic therapy such as bevacizumab. However, determining treatment failure using conventional MRI methods remains challenging. We prospectively collected longitudinal MR spectr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2cb8db45e315a531dbf735719f5158d5
https://europepmc.org/articles/PMC8598661/
https://europepmc.org/articles/PMC8598661/
Autor:
Anna Vaynrub, Mark Vangel, Deborah Forst, Ovidiu C. Andronesi, Jayashree Kalpathy-Cramer, R. Gilberto Gonzalez, Eva-Maria Ratai, Mohamed El-Abtah, Julian He, Daniel Kim, Otto Rapalino, Tracy T. Batchelor, Michael Wenke, Bruce R. Rosen, Pratik Talati, Sharif N Natheir, Jorg Dietrich, Yi-Fen Yen, Elizabeth R. Gerstner, Melanie Fu, Isabel Arrillaga-Romany
Publikováno v:
Neuro-oncology Advances
Background Determining failure to anti-angiogenic therapy in recurrent glioblastoma (GBM) (rGBM) remains a challenge. The purpose of the study was to assess treatment response to bevacizumab-based therapy in patients with rGBM using MR spectroscopy (
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9b44a8edaebe403bceaa92b786de0297
https://doi.org/10.1093/noajnl/vdab060
https://doi.org/10.1093/noajnl/vdab060
